Cubist Systematic Strategies, LLC Tiziana Life Sciences LTD Transaction History
Cubist Systematic Strategies, LLC
- $14.3 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding TLSA
# of Institutions
27Shares Held
929KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA220KShares$226,1060.0% of portfolio
-
Hsbc Holdings PLC London, X0125KShares$129,1250.0% of portfolio
-
Morgan Stanley New York, NY111KShares$113,8310.0% of portfolio
-
Zhang Financial LLC55.9KShares$57,5630.0% of portfolio
-
Ausdal Financial Partners, Inc. Davenport, IA55.7KShares$57,3710.01% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $105M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...